Enumeral Biomedical Secures $635,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69c35a61-62da-4c5a-9571-86e362e175d7
Date
2/11/2014
Company Name
Enumeral Biomedical
Mailing Address
1450 Broadway 24th Floor New York, NY 10018
Company Description
Enumeral Biomedical Corp. engages in the discovery and development of native human monoclonal antibodies for use in the diagnosis and treatment of infectious, autoimmune, and inflammatory diseases, and cancers.
Website
http://www.enumeral.com
Transaction Type
Debt
Transaction Amount
$635,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed